Valsotens HCT Malta - anglès - Medicines Authority

valsotens hct

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - hydrochlorothiazide, valsartan - film-coated tablet - hydrochlorothiazide 12.5 mg valsartan 160 mg - agents acting on the renin-angiotensin system

Valsotens HCT Malta - anglès - Medicines Authority

valsotens hct

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - hydrochlorothiazide, valsartan - film-coated tablet - hydrochlorothiazide 25 mg valsartan 160 mg - agents acting on the renin-angiotensin system

Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva Unió Europea - anglès - EMA (European Medicines Agency)

efavirenz/emtricitabine/tenofovir disoproxil zentiva

zentiva k.s. - efavirenz, emtricitabine, tenofovir disoproxil, phosphate - hiv infections - antivirals for systemic use, - efavirenz/emtricitabine/tenofovir disoproxil zentiva is a fixed-dose combination of efavirenz, emtricitabine and tenofovir disoproxil. it is indicated for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adults aged 18 years and over with virologic suppression to hiv-1 rna levels of < 50 copies/ml on their current combination antiretroviral therapy for more than three months. patients must not have experienced virological failure on any prior antiretroviral therapy and must be known not to have harboured virus strains with mutations conferring significant resistance to any of the three components contained in efavirenz/emtricitabine/tenofovir disoproxil zentiva prior to initiation of their first antiretroviral treatment regimen., the demonstration of the benefit of the combination efavirenz/emtricitabine/tenofovir disoproxil is primarily based on 48-week data from a clinical study in which patients with stable virologic suppression on a combination antiretroviral therapy changed to efavir

APO-VALSARTAN TABLET Canadà - anglès - Health Canada

apo-valsartan tablet

apotex inc - valsartan - tablet - 40mg - valsartan 40mg - angiotensin ii receptor antagonists

APO-VALSARTAN TABLET Canadà - anglès - Health Canada

apo-valsartan tablet

apotex inc - valsartan - tablet - 80mg - valsartan 80mg - angiotensin ii receptor antagonists

APO-VALSARTAN TABLET Canadà - anglès - Health Canada

apo-valsartan tablet

apotex inc - valsartan - tablet - 160mg - valsartan 160mg - angiotensin ii receptor antagonists

APO-VALSARTAN TABLET Canadà - anglès - Health Canada

apo-valsartan tablet

apotex inc - valsartan - tablet - 320mg - valsartan 320mg - angiotensin ii receptor antagonists

STAY SAFE BALANCE 1.5% glucose 1.75mmolL calcium peritoneal dialysis solution bag Malàisia - anglès - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

stay safe balance 1.5% glucose 1.75mmoll calcium peritoneal dialysis solution bag

fresenius medical care malaysia sdn bhd - calcium chloride dihydrate ph. eur.; magnesium chloride hexahydrate pheur; glucose monohydrate, ph eur; sodium chloride (nacl); sodium lactate solution (50%) -

STAY SAFE BALANCE  2.3% glucose 1.75 mmolL calcium peritoneal dialysis solution bag Malàisia - anglès - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

stay safe balance 2.3% glucose 1.75 mmoll calcium peritoneal dialysis solution bag

fresenius medical care malaysia sdn bhd - sodium chloride (nacl); calcium chloride dihydrate ph. eur.; magnesium chloride hexahydrate pheur; glucose monohydrate, ph eur; sodium lactate solution (50%) -

STAY SAFE BALANCE 4.25% glucose 1.75 mmolL calcium peritoneal dialysis solution bag Malàisia - anglès - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

stay safe balance 4.25% glucose 1.75 mmoll calcium peritoneal dialysis solution bag

fresenius medical care malaysia sdn bhd - sodium chloride (nacl); calcium chloride dihydrate ph. eur.; magnesium chloride hexahydrate pheur; glucose monohydrate, ph eur; sodium lactate solution (50%) -